PubRank
Search
About
A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
Clinical Trial ID NCT02019693
PubWeight™ 3.18
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT02019693
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
Next 100